Biblio

Export 3284 results:
Author Title [ Type(Desc)] Year
Journal Article
F. Segovia, Gómez-Río, M., Sánchez-Vañó, R., Górriz, J. Manuel, Ramírez, J., Triviño-Ibáñez, E., Carnero-Pardo, C., Martínez-Lozano, M. Dolores, and Sopena-Novales, P., “Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 765-779, 2018.
M. Asif Emran Emon, Kodamullil, A. Tom, Karki, R., Younesi, E., and Hofmann-Apitius, M., “Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 56, no. 2, pp. 677-686, 2017.
S. Gill, Mouches, P., Hu, S., Rajashekar, D., MacMaster, F. P., Smith, E. E., Forkert, N. D., and Ismail, Z., “Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”, J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
K. R. Thomas, Edmonds, E. C., Eppig, J., Salmon, D. P., and Bondi, M. W., “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
C. Lage, Suarez, A. Gonzalez, Pozueta, A., Riancho, J., Kazimierczak, M., Bravo, M., Bonilla, J. Jimenez, Torres, Mde Arcocha, Quirce, R., Banzo, I., Vázquez-Higuera, J. Luis, Rabinovici, G. D., Rodriguez-Rodriguez, E., and Sánchez-Juan, P., “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
Y. - F. Shea, Barker, W., Greig-Gusto, M. T., Loewenstein, D. A., DeKosky, S. T., and Duara, R., “Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1599-1608, 2018.
T. Porter, Burnham, S. C., Milicic, L., Savage, G., Maruff, P., Lim, Y. Ying, Li, Q. - X., Ames, D., Masters, C. L., Rainey-Smith, S., Rowe, C. C., Salvado, O., Groth, D., Verdile, G., Villemagne, V. L., and Laws, S. M., “Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1193-1211, 2018.
M. F. Bergeron, Landset, S., Zhou, X., Ding, T., Khoshgoftaar, T. M., Zhao, F., Du, B., Chen, X., Wang, X., Zhong, L., Liu, X., and J Ashford, W., “Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1545-1558, 2020.
M. J. Lan, R Ogden, T., Kumar, D., Stern, Y., Parsey, R. V., Pelton, G. H., Rubin-Falcone, H., Pradhaban, G., Zanderigo, F., Miller, J. M., J Mann, J., and Devanand, D. P., “Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 3, pp. 939-947, 2017.
C. Li, Neugroschl, J., Luo, X., Zhu, C., Aisen, P., Ferris, S., and Sano, M., “The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.”, J Alzheimers Dis, vol. 60, no. 2, pp. 427-437, 2017.
A. Pons, LaMonica, H. M., Mowszowski, L., Köhler, S., Deckers, K., and Naismith, S. L., “Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample.”, J Alzheimers Dis, vol. 62, no. 1, pp. 373-384, 2018.
Z. Shi, Zhu, Y., Wang, M., Wu, Y., Cao, J., Li, C., Xie, Z., and Shen, Y., “The Utilization of Retinal Nerve Fiber Layer Thickness to Predict Cognitive Deterioration.”, J Alzheimers Dis, vol. 49, no. 2, pp. 399-405, 2016.
S. Petersen, Houston, S., Qin, H., Tague, C., and Studley, J., “The Utilization of Robotic Pets in Dementia Care.”, J Alzheimers Dis, vol. 55, no. 2, pp. 569-574, 2017.
C. L. Greenblatt and Lathe, R., “Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.”, J Alzheimers Dis, vol. 98, no. 2, pp. 343-360, 2024.
C. L. Greenblatt and Lathe, R., “Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.”, J Alzheimers Dis, vol. 98, no. 2, pp. 361-372, 2024.
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., “Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
S. André, Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Elst, L. Vander, Laurent, S., Muller, R. N., and Burtea, C., “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
H. - W. Klafki, Hafermann, H., Bauer, C., Haussmann, U., Kraus, I., Schuchhardt, J., Muck, S., Scherbaum, N., and Wiltfang, J., “Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 691-705, 2016.
C. Xu Peh, Abdin, E., Vaingankar, J. A., Verma, S., Chua, B. Yiang, Sagayadevan, V., Seow, E., Zhang, Y. J., Shahwan, S., Ng, L. Ling, Prince, M., Chong, S. Ann, and Subramaniam, M., “Validation of a Latent Construct for Dementia in a Population-Wide Dataset from Singapore.”, J Alzheimers Dis, vol. 55, no. 2, pp. 823-833, 2017.
E. Stallard, Kociolek, A., Jin, Z., Ryu, H., Lee, S., Cosentino, S., Zhu, C., Gu, Y., Fernandez, K., Hernandez, M., Kinosian, B., and Stern, Y., “Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.”, J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.
V. Pérez-Grijalba, Fandos, N., Canudas, J., Insua, D., Casabona, D., Lacosta, A. M., Montañés, M., Pesini, P., and Sarasa, M., “Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.”, J Alzheimers Dis, vol. 54, no. 2, pp. 751-62, 2016.
M. Müller, H Kuiperij, B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., Engelborghs, S., Claassen, J. A., and Verbeek, M. M., “Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1321-33, 2016.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
A. Gomez-Ramos, Picher, A. J., García, E., Garrido, P., Hernández, F., Soriano, E., and Avila, J., “Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 56, no. 3, pp. 977-990, 2017.
X. Feng, Zhou, A., Liu, Z., Li, F., Wei, C., Zhang, G., and Jia, J., “Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1611-1618, 2018.

Pages